Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OT: Paulwarn: I'm not well read on the subject but isn't the current theory that we all funnel back to a survivor group. The other DNA and tracings are probably not available (right now)from current DNA technology. Fractured strands, what have you. I think wejust will not know for a while. The concept of parralel evolution is not "new" if we take the coexistence of Neanthedral and Cro-magnon. But since we now consider Lucy more ape-like than first supposed, we may have to consider the veil of time as concealing the answers to our questions. We may part some of that veil but I don't think any degree of scientific certainty will be forthcoming. Still it's nice to conjecture, but then we had the Piltdown Man and the Scopes trial. so who knows what we will be finally permitted to believe? I was not familiar with the Asian 2nd genesis. I'll keep an eye out and an ear clean to educate myself about it.
Stakddek
Paulwarn: My take is to agree with you. Wells had a book out and they traced the Y chromosome for his earlier work.
He appears to be the National geographic lead man on the project. NG is grooming him for a "New Explorer" status. Sort of a break in the new generation attempt. The tracing of "Y" appears to be his prefferred method. This would of course be a procedure that could be performed by DNAP and many others. The project does not appear to be designed for a mass sampling, "one hundred thousand samples" but I am sure NG will be glad to sell kits to any purchaser in excess of that number. That way Doctor Wells can cherry pick the submissions to get a more representative (global)sampling, that will allow a greater geographic spread for the samples included for study in the program. Wouldn't be much of a test if all the people in Rochester NY were the first 100,000 to donate the 100 bucks. I don't think this would suit the purposes of the show Doctor Wells is putting together, as he wishes to show all humankind is derived from a few individuals who survived the last global disaster. (or spaceship stranding - or genetic experiment of %^&&*(&% 3rd grade biology class!)
I mean if you have to pay $100.00 to be in the survey, a lot of people will not participate. I guess though that it will be reassuring to know that a National Geographic subscriber is likely descended from a progenitor in Africa from 66 thousand years ago.
It's an interesting vehicle for a show, but I feel from the reading I've perused today that Doctor Wells might be more interested in finding "Y" to Africa rhan dealing with all the possible steps inbetween.
On the other hand, they could do it right and call Doctor Frudakis!
Stakddek
Easymedicine: I regret that your current infirm state precludes you from thinking through the posting I made of the very late First Alert service. My concern was in letting all know that the false and misleading information created by the reported move to pink status was still being disemminated.
I personally would prefer that DNAP avoid the "status" conferred by such a pink listing. I was very relieved when follow up alerts were out "before the bell".
I think you will agree that the "happenstance" of the inadvertent error, occuring in such proximity to the possible sale by those who had purchased DNAP earlier in the week or last week below .006 would exacerbate any market fluctuation. I'm sure your charting skills, if you had been at your post and not incapaccitated by illness, would have had you posting here as to just about when the current upturn would end. Alas you were hospitalized and in no condition to inform us of your opinion.
A run of PPS going up and significant increase in volume I'm sure has created some interesting patterns. I wonder if you can note an effect of the "misteaken" daily List publication in the afternoon of Tuesday? It seems the rally that was curtailed has resumed for the time being. Unless of course the E-Conference is buoying the PPS.
Humor is the Best Medicine: We regret your illness. However, did your affliction come as a result of "keeping your nose to the grindstone"?
Stakddek
OT: But maybe not for DNAP!
++++++++++++++++++++++++++++
http://www.ananova.com/news/story/sm_1354004.html?menu=news.scienceanddiscovery
+++++++++++++++++++++++++++
Ananova:
Smoking's asthma timebomb
Women who smoke during pregnancy could be creating an asthma timebomb for their grandchildren.
A new US study has found that a child whose grandmother smoked when pregnant has double the risk of asthma.
A team at the University of Southern California studied the health of 1,000 children under the age of ten.
They found that if a mum smoked when pregnant, her children were 1.5 times more likely to develop asthma by the age of five.
But if the gran smoked, they were twice as likely to suffer.
If both mother and grandmother smoked, the risk was 2.5 times greater.
The study, published in medical journal Chest, is the first to probe effects on different generations.
Dr Frank Gilliland said: "This is the first study to show that if a woman smokes while pregnant both her children and grandchildren may be more likely to have asthma.
"Smoking could have a long-term impact on a family's health that's never before been realised."
Copyright © 2005 Ananova Ltd
++++++++++++++++++++++++++++++++
Stakddek
Hi Ann: I linked searched to this page at Lynn Peavey:
++++++++++++++++++++++++++++
http://www.lynnpeavey.com/product_info.php?cPath=57&products_id=804
+++++++++++++++++++++++++++++++++
Forensic Innovations for Law Enforcement and Laboratories 1-800-255-6499
» Home » Innovative Products »
Search
Innovative ProductsLatent Fingerprint DevelopingLifting and PrintingLatent Fingerprint KitsChemical Enhancement & DevelopmentAlt. Light Sources, Flashlights, and CamerasVisual Aids, Rulers, and Measuring DevicesEvidence Packaging and StorageEvidence SealsAt the Job & On the SceneImpression Evidence & VacuumsPre-Packaged KitsBiohazard and Safety SuppliesBooks, Software & VideoPromotional ItemsGarage SaleLaboratory Supplies
Contact UsThe Daily Hound2004 CatalogProcessing ManualEducation & Trade ShowsShipping InformationGet to Know UsLinksPrivacy & Security
DNAWitness Collection Kit (09596) $0.00
DNAPrint™ Genomics, Inc. introduces DNA Witness™. From a simple swabbing at the crime scene, the results will tell you the Biogeographical Ancestry (BGA) of an unknown sample.
Knowing the BGA of a sample tells you which direction to start looking…and more importantly, where not to. It may confirm that you’re on the right track, or that you’re barking up the wrong tree. It’ll tell you in precise detail if your suspect (or unknown victim) is European, East Asian, Native American, and Sub-Saharan African…all in less than two weeks!
The DNAWitness Collection Kit is provided FREE! You only pay when you send it in for processing. The processing charge is $1,000.
Contents of the kit include: one PreZerve, one IntegriSwab, a request for service form, an integrity seal, and a FedEx envelope and airbill.
DNAWitness Collection Kit (09596) was added to our catalog on Thursday 08 January, 2004.
++++++++++++++++++++++++++++++++++++++++
Stakddek
The wild ride continues!
++++++++++++++++++++++++++++
First Alert News <FirstAlertNews@stockgroupmail.com>
Sent : Tuesday, April 12, 2005 10:55 PM
To : XXXXXXXXXXXxx#XXX$ZZZ
Subject : DNAP : SmallCapCenter.com First Alert News
DNAP
First Alert News Brought To
You By:
4/12/05 7:43:30 PM
DNAP Terminated Registration
Read the full story.
OBB: DNAP
Last: 0.011
Change: -0.003
% Change: -19.23%
Volume: 49,146,140
View Full Quote
Send this press release to a friend.
Email:
Enter ticker symbols to sign up for First Alert News
Service for other public companies.
For companies trading on Canadian exchanges, use the following:
TSX-V: V.*** TSX: T.*** (***=symbol)
Edit your First Alert News Profile
You have subscribed on www.smallcapcenter.com to receive DNAP First Alert News. To stop future First Alert News for DNAP, edit your profile.
Comments? Feedback? Contact FirstAlertNews@stockgroup.com
Copyright 2003 StockGroup Media Inc. All Rights Reserved.
+++++++++++++++++++++++++++++++++++++++++
Some folks are going to end up wondering over the morning coffee. This is a situation where if the stock was listed on AMEX or NYSE they would halt trading and get the full story out before resuming trade.
Oh, and when I clicked on the link "read the full story" I went to the website with just the quote for DNAP and no other info.
Stakddek
*KUDOS to CGR on Napheads who clued me in. THANKS TO HIM. I just brought it over here. EOM
NEW INFO: I added the ******************* in the note area.
+++++++++++++++++++++++
OTCBB SYSTEM CHANGES - 04/12/2005
OTCBB Daily List
Other-OTC / Portal / PPS Daily List
SECURITY ADDITIONS
Updated Symbol Company Name Effective Date/Comments
17:19 IZON InZon Corporation Common Stock 04/12/2005 From NBB (IZON) **
17:19 LCNIA Lincoln International Corp. Class A Common Stock 04/12/2005 From NBB (LCNIA) **
17:19 MPABU Mercator Partners Acquisition Corp. Unit Series B 04/12/2005
17:19 MPAQU Mercator Partners Acquisition Corp. Unit Series A 04/12/2005
17:19 SWKJ SiteWorks, Inc. New Common Stock 04/13/2005 From NBB (SWKJ) **
SECURITY DELETIONS
Updated Symbol Company Name Effective Date/Comments
17:19 GBXX Globix Corporation New Common Stock (post bankrupt) 04/13/2005 Listed on AMEX (GEX)**
17:19 NCBS New Commerce Bancorp (SC) Common Stock 04/13/2005 Acquired by SCBT Financial Corporation ($18.00/sh) **
SYMBOL CHANGES
Updated Date Old Symbol New Symbol Name Comment
17:19 04/13/2005 MLHPE MLHP Millenia Hope, Inc. Common Stock
NAME/SYMBOL CHANGES
Updated Date Old Symbol Old Name New Symbol New Name Comment
17:19 04/13/2005 FTYLL Forest Oil Corporation Warrants 3/20/2010 FTYLL Forest Oil Corporation Warrants 5/9/2005 **
*****************************************************
Notes
The deletion from BB for DNAP, reported on the Daily List of 04/12/2005, with an Effective Date of 04/13/2005, has been cancelled.
*******************************************************
--------------------------------------------------------------------------------
All Security Symbols appended with an "E" will be ineligible for quotation and subject to removal from the OTCBB in 30 calendar days (60 days if denoted with a plus sign "+") if the NASD does not receive information indicating that the company is current in its public reporting obligations pursuant to Rule 6530.
** indicates NSCC Eligible Security (National Securities Clearing Corporation)
Questions concerning OTCBB changes should be directed to: Market Data Integrity at (203)-375-9609
Copyright © 2004. The Nasdaq Stock Market, Inc. Please read our Disclaimer and Privacy Statement.
+++++++++++++++++++++++++++++++++++++++++++++++++++
Oh- Nevermind.
Stakddek
KUDOS to CGR on Napheads who clued me in. THANKS
Orangeman: You forgot MXRT. Oh that was a scam. Sorry. Nevermind. I remember that though. If you see a crime - don't report it. Remember Kittee Genovese???
Stakddek
Gosh! Pass the Cheese. You went to a lot of trouble to discredit me. I'm sorry I said something that you didn't agree with. I thought I just repeated in paraphrase what you said. Didn't I? I mean we both agree I'm no where near as smart as you, and I obviously need help. You seemed very willing to respond to me as soon as I posted, and I hoped by sipping at the font of your wisdom my paltry holdings would one day grow to allow me to partake in some finer repast than American or Velveeta.
PS: Despite all the cheese, I don't understand the reference to "rat". Again my lack of education is showing.
Stakddek
PS: PS: I'll be sure to ask about your inference about the CEO being involved in 9/11. I guess that would preclude government contract then????
Gee Orange: You convinced me. Lets see when we are on the SHO list, meaning some shares are vapor. There is a scarcity of shares. That makes the price go down. I got it. When there are a lot of shares the price goes up 'cause we're not on the SHO list.
Right. When shares are tight the price goes down.
When price goes up there are a lot of shares.
I think I don't understand it now.
Stakddek
Thanks for your prompt and ehrrr well instant reply.
Anyone see us on the SHO list?
Stakddek
Chris what do you think about DNAP renaming the company by calling in all the shares and then issuing new certificates? Maybe DNAprint Genomics could become DNAPrint Genomics? Gosh that would certainly boil some shorts in the laundry! Of course pulling and reissuing all the valid shares would require an expense and majority stockholder approval.
Stakddek
From SEC site:
++++++++++++++++++++++
15-12G 1 v016063_form15.htm
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-30119
S.D.E. Holdings 1, Inc.
(Exact name of registrant as specified in its charter)
900 Cocoanut Avenue, Sarasota, FL 34236 (941) 366-3400
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock
(Title of each class of securities covered by this Form)
NONE
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4 (a) (1) (i) x
Rule 12g-4 (a) (1) (ii) o
Rule 12g-4 (a) (2) (i) o
Rule 12g-4 (a) (2) (ii) o
Rule 12h-3 (b) (1) (i) o
Rule 12h-3 (b) (1) (ii) o
Rule 12h-3 (b) (2) (i) o
Rule 12h-3 (b) (2) (ii) o
Rule 15d-6 o
--------------------------------------------------------------------------------
Approximate number of holders of record as of the certification or notice date: 0
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
S.D.E. Holdings 1, Inc.
Date: April 11, 2005 By: /s/ Richard Gabriel
--------------------------------------------------------------------------------
Richard Gabriel, President of
Successor Registrant
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
+++++++++++++++++++++++
SDE holdings has "0" shareholders.
KAhio? Where did you come from????
Stakddek
PS: You have me very worried. Was that the purpose of your appearance?????
OT: DORSEYE: Link on collission avoidance:
++++++++++++++++++++
http://www.all4engineers.com/index.php;do=show/lng=en/alloc=1/id=2672/sid=1e220ea19e82af1c688f414d67...
++++++++++++++++++++++
Stakddek
OT DORSEYE: Tire Device: I believe you are understating the potential market. Many new vehicles are coming equipped with colision avoidance systems. They "sense" the rotational speed of the tires and control brake application during those colission avoidance turns to prevent vehicle skidding. This is not just "straight line" ABS application but during skids, using data from sensors to aid driver. Bosche has an existing system. We are getting closer to "fly by wire" on these new vehicles, and given the lessons of the past - SUV rollovers- tire failures from overheating, perhaps your outfit will consider tire temperature as an added "data output". Obviously to us car nuts a low pressure high heat condition would mean more than just a low pressure!
PS: My new truck (Dodge Sprinter) has brake by wire! A pump pressurizes brake fluid, and a simulator system pushes back on the brake pedal!
Good luck on that stock. I think you got in early on ANOTHER winner.
Stakddek
OT: RXIRISH -- No just the message asking if I got the previous message. Ergo, I am puzzled. Please adjust pieces.
PS: I am cheap and am not a dues paying member here. I will be when DNAP hits. but til then, I'm freeloadind so no private mail reply.
Stakddek
OT: DNAP made me smile. 30 more smiles!
+++++++++++++++++++++
1.. My husband and I divorced over religious differences.....He thought he was God and I didn't.
2.. I don't suffer from insanity; I enjoy every minute of it.
3.. I Work Hard Because Millions On Welfare Depend on Me!
4.. Some people are alive only because it's illegal to kill them.
5.. I used to have a handle on life, but it broke.
6.. Don't take life too seriously; No one gets out alive.
7.. You're just jealous because the voices only talk to me.
8.. Beauty is in the eye of the beer holder.
9.. Earth is the insane asylum for the universe.
10.. I'm not a complete idiot --Some parts are missing.
11.. Out of my mind. Back in five minutes.
12.. Nyquil, the stuffy, sneezy, why-the-heck-is-the-room-spinning medicine.
13.. God must love stupid people; He made so many.
14.. The gene pool could use a little chlorine.
15.. Consciousness: That annoying time between naps.
16.. Ever stop to think, and forget to start again?
17.. Being "over the hill" is much better than being under it!
18.. Wrinkled Was Not One of the Things I Wanted to Be When I Grew up.
19.. Procrastinate Now!
20.. I Have a Degree in Liberal Arts; Do You Want Fries With That?
21.. A hangover is the wrath of grapes.
22.. A journey of a thousand miles begins with a cash advance
23.. Stupidity is not a handicap. Park elsewhere!
24.. They call it PMS because Mad Cow Disease was already taken
25.. He who dies with the most toys is nonetheless dead.
26.. A picture is worth a thousand words, but it uses up three thousand times the memory.
27.. Ham and eggs. A day's work for a chicken, a lifetime commitment for a pig.
28.. The trouble with life is there's no background music.
29.. The original point and click interface was a Smith and Wesson.
30.. I smile because I don't know what the hell is going on.
++++++++++++++
Stakddek
OT: Shorting: It is useful to remember that this regulation SHO was a recognition of a problem. It didn,t solve it. In fact as I read the wording, I could see the bucket brigade of unfilled orders being passes from one broker to another, each time being washed to a no commission trade.
Add the undesired listings on the foriegn markets where our laws are not applied, and hedge funds that can disappear overnight when the "bill comes due", (being blamed for the whole chain of illegal trading), well--- Now who would think to open a trading acount and just plan on walking away if things went sour? Well if no one was ever going to find me, or if I died four years ago...
The problem we are dealing with is greater than just "naked shorting". It might even deserve the title economic terrorism.
Stakddek
DNAP
+++++++++++++++++++++++++++
Last Trade: 0.01
Trade Time: 9:53AM ET
Change: 0.00 (8.70%)
Prev Close: 0.01
Open: 0.01
Bid: 0.01 x 5000
Ask: 0.01 x 5000
1y Target Est: N/A
Day's Range: 0.01 - 0.01
52wk Range: 0.00 - 0.05
Volume: 7,714,848
Avg Vol (3m): 6,034,359
++++++++++++++++++++++++++++
Stakddek
OT: Chuckerman:
How is your recovery going? I know you are sorta' "bionic" now, and since I hope to live long enough to require some replacements someday, hows it been? (I'm gonna' take care of all the original equipment for as long as I can, but high mileage can take a toll!)
Stakddek
Hi Geoly and all. In this economic clomate it would pay to remember that many states are trying very hard to keep business from running off to other places. Sometimes energy credits and certain tax benefits are offerred to entice companies to stay or to come and move a business to a new location. Hilal may be playing this card to receive favorable treatment from NYS for cheap energy or he may be even be offerred tax benefits and cheap energy to expand into a different state. I can only imagine what super hi-temp ceramic ovens utilize in the form of energy.
There are other benefits offered for employee training, and sometimes, an available low cost work force and cheap transportation costs become a factor. Even proximity to your customers.
In other words, there are ingredients in the mix that we don't know about, and all the reading we do on these message boards is not going to inform us of every factor involved in management decisions.
Until formal reports are forthcoming this is a pink phantom that you've placed a bet on. If you bet because of hype and lies on a bullettin board, shame on you. If you bet because you saw value, well let's all hope our trust is not betrayed.
Stakddek
Press Release Source: Cetek Technologies, Inc.
Cetek Announces Acquisition
Monday April 4, 9:30 am ET
POUGHKEEPSIE, N.Y.--(BUSINESS WIRE)--April 4, 2005--Cetek Technologies, Inc. (Pink Sheets:CTKH - News) today announced the acquisition of Hybrid-Tek, Inc., a thick film on ceramic manufacturer. This acquisition is a 100% (wholly owned) subsidiary of Cetek Technologies, Inc.
Regarding the acquisition, the company is a New Jersey-based manufacturer that has been in continuous operations since 1982. The acquired company specializes in high quality thick film technology on ceramic for aerospace and various other applications. Thick film technology is the process by which circuitry is placed on ceramic substrates.
As previously stated, the growth of Cetek would be from internal expansion by product and customer additions, as well as by acquisition of manufacturing companies with similar synergies. This particular acquisition is expected to take advantage of various synergies that should serve to complement Cetek's operations.
Cetek CEO Fayiz Hilal stated, "This acquisition will provide more exposure to Cetek Technologies, as well as for Cetek's ceramic into more markets. This company has considerable talent and growth potential, which should most certainly enhance Cetek's overall business model. We are pleased to be able to make this announcement, and we will provide more information as warranted."
About Cetek Technologies
Cetek Technologies' principal activity is to market and manufacture ceramic products for several different industries. Cetek products are of high grade industrial ceramics including alumina, cordierite, mullite, and zirconia for thermal shock, wear, electrical isolation and corrosial resistance applications. Cetek's substrates are commercially produced in 12 inch, as well as larger size, panels.
--------------------------------------------------------------------------------
Contact:
Stock Enterprises
Jim Stock, 702-274-5400
http://www.hybrid-tek.com/products.html
+++++++++++++++++
Stakddek
Tomshardwarenews ++++++++++++++++
Shortages of LCD panel materials could mean higher LCD prices
By Wolfgang Gruener, Senior Editor
March 31, 2005 - 13:18 EST
El Segundo (CA) - Market research firm iSuppli reports that materials and components used for the manufacturing of large-sized LCD panels are likely to enter a state of shortage in the second half of 2005 and result in price increases for computer monitors.
According to the report released this week, supply of glass substrates for large-sized TFT-LCD panels with sizes of 10 inches and more is expected to fall 8 to 10 percent short of demand in the second half of the year. In addition to that, color filters used for fifth- and sixth-generation LCD fabs are forecasted to experience shortages of 7 to 12 percent in the fourth quarter. Further shortages are predicted for polarizers, TAC film and lamps.
iSuppli believes the upcoming shortages can be explained with the industry downturn in the third quarter of 2004 as shipments of panels for desktop PC monitors declined and demand for displays for mobile computers grew only marginally. As a result, materials used in the production of large-sized panels went into a state of oversupply late last year.
According to the market research firm, material suppliers presently are limiting production increases as a reaction to conditions in 2004. Because of this, it is likely that materials production will not keep pace with panel manufacturing in the second half of 2005, iSuppli predicts. Materials suppliers typically require one quarter to respond to shifts in LCD shipment levels.
Product shortages typically have an immediate effect on market prices of products. iSuppli agreed that it is likely that price increases are likely during this year, but was careful to say how dramatic the effect will be.
"We believe the glass shortage will have some impact on the supply/demand situation for LCD panels in 2005. It will definitely impact the capability of LCD panel suppliers to fulfill their manufacturing expansion plans for 2005," said Sweta Dash, Director, LCD and Projection Research at iSuppli.
"We are already seeing a shortage situation for 17-inch desktop PC monitor panels and panel pricing has begun to increase, starting at the end of February. Price reductions for notebook and TV panels also have slowed down in the first quarter. We think the impact of the shortage will fall more on the monitor market than on the TV market," he said.
Considering the price erosion of LCD panels in the past few years, the shortage of materials is not just negative for the industry, but could provide a tool to stabilize or even increase pricing levels. LG already had complained at CeBit about "artificially" low prices in the LCD market and announced intentions to increase prices this year by about five percent. Looking at iSuppli's forecast, these price increases may not be too hard to justify after all.
RETURN: Hard News Index
++++++++++++++++++++++++++++++++
Stakddek
Video News Story on Naked Shorting:
++++++++++++++++++++++++
DWJ Television is a broadcast public relations company with more than 30 years of experience producing and placing radio and television programming for corporate and public relations agency clients. DWJ produces a wide range of radio, TV, video and Internet projects, including video news releases, satellite media tours, Webcasts, radio series, audio news releases, remote radio tours, teleconferences, public service announcements, corporate and marketing videos, CD-ROMS and DVDs.
+++++++++++++++++++++++
http://www.dwjtv.com/clips/windowsmedia/hosting/ncans2_999.asx
++++++++++++++++++++++
Stakddek
Frog: You are so considerate of us. Thank you for all your joy you manage to spread. I'm sure from the abundance of manure you've expelled many lovely flowers will bloom and the sweet fragrance will obliterate the stench of your "recreational" efforts.
Stakddek
OT: I'm trying to remember who said, "IT'S THE EARLY WORM WHO GETS THE BIRD", but I can't seem to attribute it. Closest guess was Larry Moe or Curly, and possibly the short where they spoof Hitler and the axis, but I can't remember. Any film buffs out there? Just something brought it to mind, and I didn't want to annoy Doug with my problems. He can sometimes be a strict taskmaster about remaining on topic.
Stakddek
PS: A film buff is someone who knows much about the art. Not someone who views TV in the nude. Just in case anyone would feel uneasy about my query!
GMED CONFUSION TO ABOUND!
+++++++++++++++++++++
http://washington.bizjournals.com/washington/stories/2005/03/14/daily30.html?jst=b_ln_hl
++++++++++++++++++++++
+++++++++++++++++
LATEST NEWS
RSS Feeds / Reprints / E-mail Alerts / Printable Version / Email Story
Washington Business Journal - 2:57 PM EST Friday
French firm sets up U.S. office in Silver Spring
Neil Adler
Staff Reporter
G-Med was looking to open a U.S. headquarters to be closer to its American customers, so the French company set its sights on Washington. Because it employs auditors who monitor and certify the quality and safety of medical devices made by manufacturers, being near the U.S. Food and Drug Administration seemed like the best idea.
The FDA is housed in numerous offices in and around Rockville, so the Maryland Technology Development Center, an incubator primarily for biotech companies, was the perfect spot for G-Med to land. But it wasn't that easy. The Rockville facility is full.
The new 22,000-square-foot technology incubator in Silver Spring, focused on information-technology companies, had room. And because the FDA is consolidating its offices at a massive new campus in White Oak, which is right next to Silver Spring, the second choice became the first choice.
The company -- made up of Marc-Henri Winter, president of G-Med North America, the new subsidiary of Paris-based G-Med (www.gmed.fr), and another employee -- recently took a small suite at the Silver Spring Innovation Center, which cost $2.5 million to build and opened last year.
"G-Med is a perfect fit for the Silver Spring area and for the county at large," says David Edgerley, director of the Montgomery County Department of Economic Development, which operates the Silver Spring and Rockville incubators. "Now any company wishing to sell its product in Europe, Canada, Taiwan or the United States will have a huge advantage by being in Montgomery County."
The incubator is about 80 percent occupied, with several businesses planning to take space soon that would completely fill it up, says Joe Shapiro, a spokesman for the economic development department. G-Med hasn't applied for any loans or grants with the county, but Shapiro says his department would be happy to provide financial assistance to the startup if it qualifies.
Shapiro says G-Med was a good win for the incubator and the county because economic development officials are trying to land more international companies. Further, these officials predict that medical companies will set up in the eastern part of the county because of the FDA's relocation to White Oak. G-Med is one of the first examples.
"For the company to start out here makes sense," Shapiro says.
G-Med North America, which works only with U.S. companies, will hire an engineer this year, and Winter plans to have six employees by 2007.
In France, G-Med employs 45 and conducts audits for companies looking to sell their devices there and in countries such as Australia, Japan, New Zealand, Taiwan and Canada. The parent company, Paris-based LNE (www.lne.fr), has 750 workers and is profitable.
» Continued
Page: 1 / 2
« Continued from previous page
Among G-Med's 80 U.S. customers -- and 800 around the world -- is General Electric. Winter says he hopes to land more customers in the United States with the help of his new office.
"We really wanted to be in the United States," says Winter.
When scouting for a U.S. headquarters, G-Med focused on the East Coast, where many of its customers are. Winter says access to an international airport and other transportation systems put Boston and D.C. in the running.
New York City was left out because it's "too expensive," he says. With space available at the Silver Spring incubator and Winter having family in the Washington area, the decision became easy.
G-Med North America will stay in the incubator for two to three years then graduate into its own commercial space somewhere in Montgomery County. But for now, Winter is trying to adjust to living in the United States and slowly build up his business.
"It's difficult to imagine the tasks we need to do," he says.
« Previous
Page: 1 / 2
© 2005 American City Business Journals Inc.
+++++++++++++++++++++++++++++++++++++++++++++++++++
Confusion????
Stakdddek
Bendriver! I thought you editorialzed the GROAN, and then I saw my mailvox with that genomeweb alert. Maybe us DNAPppers are not the only ones hung out to dry waiting for the release. I didn't like the tentative tuesday comment. Oh well.
Stakddek -- Happy Saint Patricks' Day to us all.
Thanks Blurjuggernaut. Your report on patent activity and how to check it is much appreciated. Please don't be afraid to post further info if you run across it. Thanks for sharing.
Stakddek
Naked shorting: More story:
++++++++++++++++++++++
http://www.investigatethesec.com/DP110305.htm
++++++++++++++++++++++
STOCKGATE TODAY
An online newspaper reporting the issues of Securities Fraud
SEC’s Donaldson to Senate on Naked Shorting “Shorting Selling is not Illegal” – March 10, 2005
David Patch
For those fighting the uphill battle of abusive naked shorting the March 9th Senate Hearing with Chairman Donaldson was at least amusing to watch.
In a pre-arranged agenda for the Senate Hearing with SEC Commissioner William Donaldson on the Financial Markets, Utah Senator Robert Bennett wanted to talk about naked shorting. Chairman Donaldson did not address the issue in his opening remarks but it was on the agenda none the less. The amusement came when the floor was given to the Senator from Utah and he launched into the naked shorting story.
The Senator started by reading a telling story of the fraud utilizing a Friday March 4, 2005 Financialwire news article about Global Links and their new “owner”. The Friday March 4 article was about a shareholder that had purchased 100% of a Companies security and has filed with the SEC the nature of that ownership. The Stock, with one person on file as having 100% ownership continued to trade heavy volume over the ensuing weeks trading the equivalent of nearly 100 times the outstanding shares. The Senator went on to read the trading volumes raising his voice inflections as he read off “and the next day 37, 044,500 shares traded and then another 22,471,600 the day after”. With each number stated a long look and pause at the Chairman sitting at the table across from the panel.
Senator Bennett: “Thirty three million shares traded in a single day when there are only one Million shares available and there is one investor who has filed a statement with you that he has all of them. That’s clearly something that needs work”
Chairman Donaldson, with the smirk of a cat who just ate the canary responded, "As you yourself note, short selling is not illegal". As if trading thirty three times the entire shares outstanding in a single day is merely simple legal short selling.
Senator Bennett quickly corrected the bewildered Chairman addressing him on the specific issue being addressed, naked shorting. "I approve of short selling; it's the naked short selling we're going after." This as if maybe the Commissioner glossed over the agenda where naked shorting was one of the subject matters. The animations of the Senator and the extended pauses over critical points were clear. While the canary may be gone, the feathers were still in the cat’s mouth.
As the Chairman continued his bewilderment by fumbling verbally for a clear response to the Senator and fumbling physically through a manual that must not have contained much by way of insight on naked shorting the Senator concluded by dismissing the conversation to a later date. The Senator leaving the subject with finality “"My main message here is that the evidence is Rule SHO is not working, so that's what we need to get into in detail."
The amusement here is not that Chairman Donaldson appeared clueless to address this issue but that he actually tried once again to pull the wool over the Senate’s eyes. The Chairman instantly redirected the conversation from the illegal acts of naked shorting to the legal act of shorting through a simply smirk as if to confuse the Senate. No confusion here.
Recall in earlier STOCKGATE TODAY editorials published we had caught the SEC trying to mislead the Senate on inquiries about naked shorting abuses pertaining to Jag Media Holdings. Last September Asst. Director of Market Regulation James Brigagliano responded to Senator Sarbanes inquiries with a trail of intended misdirection’s. With the Senator providing April 2003 brokerage and clearing firm e-mail evidence of settlement failures they could not address the SEC dismissed the memos as issues pertaining to company actions. Mr. Brigagliano claimed that the e-mail evidence of fails occurred due to a corporate action taken by the company and yet, under an SEC filing, that corporate action was exercised in June of 2004 and the e-mails were dated April 2003, nearly 14 months prior to the corporate action. To the best of my knowledge, and that of the constituent that filed the complaint to the Senator, the original issues pertaining to the e-mails and the inability to settle trades in Jag Media were never addressed. The SEC successfully diverted the issue away as if the e-mails never existed.
To the SEC nothing is about naked shorting. Every Investor and Issuer complaint will be thrown back at the injured by placing blame on the issuer and blaming the investor for investing in that security. Never is it Wall Street and naked shorting. That logic would work well except it was also the SEC that admitted naked shorting abuses occur.
We have yet to see any enforcement on naked shorting abuses. We have yet to see any corrective measures to the confirmed abuses the SEC referenced in their October 2003 proposal for Regulation SHO. Funny thing is we have not heard the SEC admit to any abuses within any of the companies that have claimed it to have happened to them. Nobody is abused! Which just begs the question: If naked shorting abuse exists according to the SEC in Regulation SHO Proposal, and none of the hundreds of companies vocalizing concern are being abused by the process according to the SEC, and with hundreds of companies also being listed daily on the SEC’s Regulation SHO threshold list as having high settlement failures, exactly who are the companies the SEC was referring to when they published the Regulation for comment and when they released it nine months later? The SEC has refuted each and every issuer voicing a complaint and instead goes after the company for taking their concerns public like rabid IRS agents.
By now you would have thought the SEC would have learned that public opinion and trust is not on their side. They misdirect too frequently for us to believe in them. Far too often we have seen the deer in the headlights look from Chairman Donaldson as he attempts to placate those who know better with that patented smirk of his.
Senator Bennett said it right – SHO is not working. What are you going to do Chairman Donaldson, continue to protect Wall Street’s fraud or deal with it once and for all? The casual nature of Mr. Donaldson to this issue and the mocking smirk for those abused are reason one why those abused have little confidence in the man or the agency. Presentation alone breeds distrust.
For the record, the SEC had no comment on the Senate Hearing and the obvious lack of preparedness by the Chairman to an agenda item. Maybe the SEC will file to have Global Links de-listed and then those 50 Million shares illegally sold recently can simply ----- Vanish ----- as all the other illegal trades have done with the SEC’s accelerated efforts to de-list companies.
The recorded hearing can be located at
http://banking.senate.gov/index.cfm?Fuseaction=Hearings.Detail&HearingID=140 Time Spot 1:19:45
For more on this issue please visit the Host site at www.investigatethesec.com .
Copyright 2005
+++++++++++++++++++++++
Stakddek
Naked Shorting Cont:
++++++++++++++++++++
http://www.faulkingtruth.com/Articles/Investing101/1019.html
++++++++++++++++++++
The online newspaper that's not afraid to tell...
The Faulking Truth
--------------------------------------------------------------------------------
- BLOGFEST 2005!
Because sometimes we're just
too lazy to write a real article...
--------------------------------------------------------------------------------
HOME
--------------------------------------------------------------------------------
What The Faulk
Were They Thinking?
--------------------------------------------------------------------------------
CURRENT COLUMNS
- Editor's Corner
- Blogfest 2005
- Commentary
- Commentary Too
- Down The Middle And To...
- Faulking Around
- Global Warning
- This guy walks into a bar...
- Investing 101
- Letters To the Editor
- Words
--------------------------------------------------------------------------------
ARCHIVES
--------------------------------------------------------------------------------
GUESTBOOK -
What Do You Really Think?
--------------------------------------------------------------------------------
LINKS
--------------------------------------------------------------------------------
Send Us Your
Worthless Opinion!
--------------------------------------------------------------------------------
Investing 101 - Mar 10, 2005
- Stockgate Goes to Congress
by Mark Faulk
Congress finally took the first steps towards addressing the naked short selling issue known as "Stockgate" yesterday when, in a whirlwind week that began with a major court ruling in a lawsuit pertaining to naked short selling, gained momentum when a Michigan man provided Congress with a clear "smoking gun", and culminated with Senator Robert Bennett telling SEC Chairman William Donaldson in a Senate hearing that "Rule SHO is not working".
Letting the Courts Decide
In what attorney Wes Christian described as "a significant victory in our on going battle to bring restitution to our clients for the brazen manipulations that were perpetrated against them", a New York court last week ordered the Depository Trust and Clearing Corporation (DTCC) to produce trading records for shares of Eagletech Communications (OTCBB: EATC). Eagletech, who was represented in the motion by Christian Smith & Jewell of Houston, Texas and Koerner Silberberg & Weiner, LLP, of New York City, is a plaintiff in a stock manipulation action pending in the state of Florida. It commenced a special proceeding in the Supreme Court of the State of New York to obtain certain trading reports from the Depository Trust and Clearing Corporation.
It was the first major ruling against the DTCC in the naked short selling scandal, and could open the door for other similar rulings in the dozens of cases filed by Christian, famed attorney John O'Quinn (of the Houston law firm of O’Quinn, Laminack and Pirtle), and others on behalf of companies and investors who claim that they have been victimized by naked short selling. Christian and O'Quinn have also won favorable rulings on on behalf of Exotics (OTCBB: EXII).
The Smoking Gun
In what was the most significant development this week, a Michigan man, Robert C. Simpson, claimed to have acquired 100% of the shares of Global Links Corp (OTCBB: GLKCE), filed his purchase with the SEC, and , according to Financial Wire, had the certificates delivered to him, and then watched as over 50 million shares traded over the next two days. In fact, GLKCE traded another 447,000 shares just yesterday. How did major brokers buy and sell tens of millions of shares of stock in a company that had zero shares available? It's a question that the SEC, the DTCC, and the brokers themselves will have to answer in the coming weeks.
And, if that wasn't enough, another investor, Paul J. Floto of Dallas, Oregon, bought another 15% of Global Links' stock just his week, and filed his shares with the SEC as well, even though Simpson had filed his claim to 100% of the shares of the same company a month earlier. This is how Floto described his purchase in his SEC filing ( http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3321340 ):
"On February 3, 2005 a single investor reportedly purchased all the
common shares issued by the company, plus 145 additional unissued shares.
Subsequent to that date, over 95 million shares, or over 82 times the
total shares issued, were reportedly traded, none of which were reportedly
sold by the 100% owner of the common stock.
On March 4 and 7, I purchased a total of 180,000 shares, resulting in
my obtaining 15.54% ownership of a stock reportedly already 100% owned by
another investor. I assume that there may be additional investors who may
also claim ownership of common shares of this company.
I have requested that certificates be issued to me representing my full
15.54% ownership interest, to protect my right to vote and enforce any other
claims that may accrue to an actual documented owner.
I understand that Reg. SHO was supposed to detect and prevent the
fabrication of millions of nonexistent shares. It would appear that my
securities purchases prove that Reg. SHO has been systematically violated
by market-making brokers and securities-clearing firms.
From time to time I may continue to purchase additional securities on
the open market to increase my ownership interest to up to 100% of the
company's common stock to give me an ownership interest equal to that of the
current 100% owner."
Major Media Coverage
While this has been largely a grassroots effort in the past, with only a handful of publications covering the story, including www.faulkingtruth.com , www.financialwire.net , www.investigatethesec.com , and Judith Burns of Dow Jones, there has been an upsurge in media coverage lately, as the major media has finally begun to recognize the significance of the story. But while media outlets such as the San Antonio Express-News and WNBC in New York have done recent stories on Stockgate, NBC's Dateline continues to sit on a segment that has been in the works for well over a year. Their segment, which was originally scheduled to air in early 2004, has been postponed numerous times, and, according to our sources, is now scheduled to air "sometime before April 15th". I'll believe it when I see it. After the events of the past few weeks, the scandal might be well on its way to being resolved by the time Dateline finally gets their act together.
Congress To SEC: "Regulation SHO is Not Working"
While thousands of investors have joined advocates for stock market reform in speaking out publically, others have been quietly working behind the scenes to convince Congress to launch an investigation into the naked short selling scandal. We have been working with a number of people who have been busy lobbying members of Congress to take steps to end the rampant corruption that has plagued the market for years, and yesterday, those efforts finally began to pay off.
In a hearing in the US Senate Committee on Banking, Housing, and Urban Affairs, Senator Robert Bennett grilled SEC Chairman William Donaldson about the naked short selling scandal, citing the Global Links story and opening his statement by telling Donaldson "You put out a new rule in January to deal with naked short selling, and as nearly as I can tell from my constituents, who feel victimized by this - it's not working." He then went on to read from the Global Links article and said that "this article just last Friday in a national publication indicates that people are still selling short shares that they don't have and clearly are never gonna acquire."
When Donaldson tried to argue that "short selling is not illegal", Bennett interrupted him by saying "I approve of short selling, it's the naked short selling we're going after." Donaldson then tried to describe how the recently enacted Regulation SHO dealing with the naked short selling problem, and was again interrupted by Senator Bennett, whose final comment was "My main message here is that the evidence is Rule SHO is not working, so that's what we need to get into in detail." He concluded by directing Donaldson to present an "in depth briefing" to the committee.
What Now?
This is a major victory for those of us who have often felt as if we have been beating our heads against the wall in this crusade. Mark this day down on your calenders as the day that our voices were finally heard in the halls of Congress, but be aware that this is only the beginning, there is much work yet to be done. Now is the time to step up efforts to spread the word like never before, to contact Senator Bennett and all the members of the US Senate Committee on Banking, Housing, and Urban Affairs, the Senate Finance Committee, as well as your own Congressmen and Senators. Tell them that we demand justice. Remind them that President Bush wants to invest our Social Security money into a stock market where corruption is rampant. Tell them that a full Congressional investigation is the only solution to this national scandal, and continue to spread the word to the media and through the internet. Then, and only then, will our markets once again be safe for investors.
--------------------------------------------------------------------------------
To contact members of the US Senate Committee on Banking, Housing, and Urban Affairs, go here and click on the members' names:
http://banking.senate.gov/index.cfm?FuseAction=Information.Membership
To contact members of the Senate Finance Committee, go here and click on the members' names:
http://finance.senate.gov/sitepages/committee.htm
To listen to Senator Robert Bennett's testimony and SEC Chairman William Donaldson's response from the March 9th US Senate Committee on Banking, Housing, and Urban Affairs hearing, go here, click on "Video Archive" and fast forward to 1:19:30:
http://banking.senate.gov/index.cfm?Fuseaction=Hearings.Detail&HearingID=140
(Editor's note: Correction: Robert Simpson has NOT received his GLKCE stock certificates, as was originally reported by www.financialwire.net . Although he has requested them from his broker, they have yet to deliver them to his possession. We will keep you updated as new information becomes available.)
--------------------------------------------------------------------------------
Add your name to our "Stockgate activist list" at info@faulkingtruth.com. We will email you only when we have new articles or information dealing with this issue. Please link the articles everywhere you can, post them on stock message boards, and send them to the appropriate public entities. To enact positive change requires positive action.
--------------------------------------------------------------------------------
Post your opinion in our Guestbook at http://www.faulkingtruth.com/GuestBook/
--------------------------------------------------------------------------------
Investing 101 Archives:
Financial Terrorism in America (Mark Faulk, Mar 19, 2004)
Pump and Dump or Short and Distort? (Mark Faulk, Apr 18, 2004)
Response From Berliner Freiverkehr and The Berlin-Bremen Stock Exchange (The Faulking Truth, Jun 3, 2004)
The Berlin Connection? SEC and NASD to Meet With German Brokerage Firm Tomorrow (Mark Faulk, Jun 3, 2004)
Is Dateline Losing Credibility Over StockGate Story Delays? (Mark Faulk, Jun 11, 2004)
Who's Looking Out For You? SEC Critics Seeking Investigation (Mark Faulk, Jun 27, 2004)
He Said, She Said: SEC, NASD At Odds Over Status of Proposal (Mark Faulk, Aug 5, 2004)
The Berlin Connection: 250 Companies Out (And Counting) (Mark Faulk, Aug 30, 2004)
Jag Media Case Dismissed by Judge, Citing Filing Deficiencies (Dave Patch, Sep 9, 2004)
A Twelve Step Program to Clean up the OTC Stock Market (Mark Faulk, Sep 14, 2004)
Is Time Running Short in StockGate Scandal? (Mark Faulk, Oct 5, 2004)
Dateline: The Waiting is the Hardest Part (Mark Faulk, Nov 16, 2004)
Death of an Investment Class (Dave Patch, Dec 30, 2004)
Elgindy Trial Illustrates Incompetence at the Federal Levels (Dave Patch, Jan 4, 2005)
The Year of the Investor (Mark Faulk, Jan 5, 2005)
Regulation SHO’s Threshold Lists Leave More Questions than Answers (Dave Patch, Jan 11, 2005)
Feeding the Stock Market Beast (Mark Faulk, Jan 11, 2005)
Economic Corruption US Style (Joel S. Hirschhorn, Feb 27, 2005)
Stockgate Goes to Congress (Mark Faulk, Mar 10, 2005)
Post your opinion in our guestbook:
http://www.FaulkingTruth.com/GuestBook/
+++++++++++++++++++++++++++++++++++++++++++++++
Naked Shorting? Interesting story.
+++++++++++++++++++++++
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=3299823)
+++++++++++++++++++++++
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(RULE 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(a) AND
AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(a)
GLOBAL LINKS CORP.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
379408305
(CUSIP Number)
ROBERT C. SIMPSON
1549 N. Leroy Street, Suite D-200, Fenton, Michigan 48430
(810) 714-2978
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
FEBRUARY 3, 2005
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sec. 240.13d-1(e), 240.13d(f), or 240.13d(g), check the
following box [_].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 240.13d-7 for other
parties to whom copies are to be sent.
1
<PAGE>
--- ---------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Robert C. Simpson
--- ---------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
--- ---------------------------------------------------------------------------
3 SEC USE ONLY
--- ---------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
--- ---------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS
2(d) or 2(e) [_]
--- ---------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
------------------ ------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 1,158,209 shares of the common stock of the Issuer
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
------------------ ------------------------------------------------------------
8 SHARED VOTING POWER
None
------------------ ------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
1,158,209 shares of the common stock of the Issuer
------------------ ------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
None
--- ---------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,158,209 shares of the common stock of the Issuer
--- ---------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [_]
(SEE INSTRUCTIONS)
--- ---------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
100% of the common stock of the Issuer
--- ---------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
--- ---------------------------------------------------------------------------
2
<PAGE>
ITEM 1. SECURITY AND ISSUER.
This statement relates to the common stock of Global Links Corp., a Nevada
corporation (the "Issuer"). The principal executive offices of the Issuer are
located at 3571 East Sunset Road, Las Vegas, Nevada 89120.
ITEM 2. IDENTITY AND BACKGROUND.
Pursuant to Rule 13d-1(k)(1) of Regulation 13D-G of the General Rules and
Regulations under the Securities Exchange Act of 1934, as amended (the "Act"),
this Schedule 13D is hereby filed by Robert C. Simpson, an individual (the
"Reporting Person"). The Reporting Person's business address is 1549 N. Leroy
Street, Suite D-200, Fenton, Michigan 48430. The Reporting Person is the
president, chief financial officer, secretary and director of Zann Corp. Zann
Corp. is in the business of forming strategic relationships with client
companies to accelerate their performance.
On February 3, 2005, the Reporting Person acquired 1,158,209 shares,
constituting 100 percent of the issued and outstanding common stock of the
Issuer, in the open market.
During the last five years, the Reporting Person (a) has not been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors),
and (b) was not a party to a civil proceeding of a judicial or administrative
body of competent jurisdiction as a result of which was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.
The Reporting Person is a citizen of the United States of America.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
The Reporting Person used $5,205.00 of his personal funds as consideration
for the purchase of the 1,158,209 common shares of the Issuer.
ITEM 4. PURPOSE OF TRANSACTION.
The Reporting Person acquired his interest in the Issuer solely for
investment purposes.
Other than the completed stock purchase transactions described in Items 3
and 4, except as discussed below, the Reporting Person has no present plans or
proposals that relate to or that would result in any of the following actions:
1. The acquisition by any person of additional securities of the Issuer,
or the disposition of securities of the Issuer;
2. An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any of its
subsidiaries;
3. A sale or transfer of a material amount of assets of the Issuer or any
of its subsidiaries;
4. Any change in the present board of directors or management of the
Issuer, including any plans or proposals to change the number or term
of directors or to fill any existing vacancies on the board;
5. Any material change in the present capitalization or dividend policy
of the Issuer;
6. Any other material change in the Issuer's business or corporate
structure;
7. Changes in the Issuer's charter, bylaws or instruments corresponding
thereto or other actions which may impede the acquisition of control
of the Issuer by any person;
8. Causing a class of securities of the Issuer to be delisted from a
national securities exchange or to cease to be authorized to be quoted
in an inter-dealer quotation system of a registered national
securities association;
3
<PAGE>
9. A class of equity securities of the Issuer becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Act;
or
10. Any action similar to any of those enumerated above.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
The Reporting Person may be deemed to be the beneficial owner of 1,158,209
shares of the common stock of the Issuer which constitute 100 percent of the
outstanding shares of the common stock of the Issuer.
Other than the transactions described in Items 3 and 4 above, there have
been no transactions in the common stock of the Issuer by the Reporting Person
during the last 60 days.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
To the best knowledge of the Reporting Person, there are no contracts,
arrangements, understandings or relationships (legal or otherwise) between the
Reporting Person and any other person with respect to any securities of the
Issuer, including but not limited to, transfer or voting of any of the
securities of the Issuer, finder's fees, joint ventures, loan or option
arrangements, puts or calls, guarantees of profits, division of profits or loss,
or the giving or withholding of proxies, or a pledge or contingency the
occurrence of which would give another person voting power or investment power
over the securities of the Issuer.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
SIGNATURE
After reasonable inquiry and to the best of the knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 28, 2005.
--------------------------------------
Robert C. Simpson
4
<PAGE>
</TEXT>
</DOCUMENT>
+++++++++++++++++++++++
100% ownership. Now what was the trading for March?????
Stakddek
ORCH is reporting, has a good report. Conference call today. Perhaps some info can be gleaned???? DNAP is being sorely pressed and somehow, as horrible as I feel about my investment dollars, I have empathy for Doctor Frudakis as his dream is assailed from all sides. Was it Thomas Payne who wrote about sunshine soldiers or such? If anytime it was necessary to support the company, it's now. Also noted that Biofrontera has often "failed to consummate" other merger and "aquizitions" in the past.
That said, we still have that asian connection out there don't we?
Stakddek
++++++++++++++++++++++
http://biz.yahoo.com/prnews/050310/nyth061_2.html
++++++++++++++++++++++
Press Release Source: Orchid BioSciences
Orchid BioSciences Reports Fourth Quarter and Full Year 2004 Financial Results
Thursday March 10, 7:00 am ET
- Achieves Annual Revenue Growth of 24 Percent -
- Achieves Second Quarter of Positive Operating Income -
PRINCETON, N.J., March 10 /PRNewswire-FirstCall/ -- Orchid BioSciences, Inc. (Nasdaq: ORCH - News), a leading worldwide provider of identity DNA testing services, today reported financial results for the fourth quarter of 2004 and year ended December 31, 2004.
ADVERTISEMENT
Total revenues were $17.6 million for the fourth quarter of 2004, an increase of 29 percent from the fourth quarter of 2003. Total revenues were $62.5 million for the year ended December 31, 2004, up 23 percent from the year ended December 31, 2003. The revenue growth for the fourth quarter and full year of 2004 was primarily driven by an increase in testing volume, particularly in forensics as well as private human identification and family relationship testing.
"2004 was a pivotal and transitional year for Orchid. Our overall goal for 2004 was to build upon our previous restructuring activities, position the company for further growth and cement our leadership position in our DNA testing markets," said Paul J. Kelly, M.D., chief executive officer of Orchid. "We grew revenues by more than 20 percent for the full year by capturing increasing amounts of federal funding, by expanding our market share in select core market areas, and by entering into new markets. We expanded each area of our business, particularly in forensics testing in both the U.S. and U.K. and in our family relationship testing in the U.S., which includes direct-to-consumer private paternity and our new IDSecure(TM) security service."
Dr. Kelly continued, "A key legislative event during the fourth quarter of 2004 was the Congressional enactment of the President's DNA Initiative, which provides significantly increased funding to process DNA backlogs and further populate convicted felon databases. We expect that this initiative will be a catalyst for broad-based DNA testing in the U.S. criminal justice system in the future and believe that this represents a substantial market opportunity for laboratories like Orchid."
Gross margin for the fourth quarter of 2004 was 48 percent, compared to gross margin of 44 percent in the fourth quarter of 2003. Gross margin for the fourth quarters of 2004 and 2003 includes a $1.0 million royalty. Service revenue gross margin for the fourth quarter of 2004 was 45 percent, compared to service revenue gross margin of 39 percent in the fourth quarter of 2003.
Total operating expenses were $17.1 million for the fourth quarter of 2004, compared to $15.4 million for the fourth quarter of 2003, an increase of 11 percent. The increase in operating expenses was primarily due to an increase in cost of service revenue related to the corresponding increase in service revenue. The company incurred Sarbanes Oxley compliance and audit costs of $1.5 million for the full year of 2004.
Orchid reported income from continuing operations of $0.8 million, or $0.04 per share allocable to common stockholders, for the fourth quarter of 2004, compared to a loss of $2.0 million, or $0.21 per share, for the fourth quarter of 2003. The income from continuing operations before income taxes was $0.4 million for the fourth quarter of 2004, which includes charges of $1.6 million for depreciation and amortization, as compared to a loss of $1.9 million for the fourth quarter of 2003, which includes charges of $1.3 million for depreciation and amortization.
Orchid reported net income allocable to common stockholders of $0.7 million, or $0.03 per share, for the fourth quarter of 2004, compared to a net loss allocable to common stockholders of $7.3 million, or a loss of $0.46 per share, for the fourth quarter of 2003.
Orchid reported a loss from continuing operations of $8.0 million, or $0.42 per share allocable to common stockholders, for the year ended December 31, 2004, compared to a loss of $14.3 million, or $1.42 per share, for the year ended December 31, 2003. Orchid's loss from continuing operations before income taxes was $6.9 million for the year ended December 31, 2004, which includes charges of $5.9 million for depreciation and amortization, as compared to $12.7 million for the year ended December 31, 2003, which includes charges of $5.9 million for depreciation and amortization.
Orchid reported a net loss allocable to common stockholders of $10.0 million, or $0.46 per share, for the year ended December 31, 2004, compared to a net loss allocable to common stockholders of $27.5 million, or a loss of $2.14 per share, for 2003.
At December 31, 2004, cash and cash equivalents and short-term investments were $30.5 million, and the short and long-term portion of restricted cash was approximately $2.0 million. Cash used in operations in the fourth quarter of 2004 was $3.0 million, which was negatively impacted by pay down of accrued liabilities including a U.K. tax payment and by an increase in accounts receivable primarily attributable to increased sales activity in the latter half of the quarter.
"An important initiative at the beginning of 2004 was the capital restructuring we completed in the first quarter, which fortified our balance sheet and gave us a solid foundation for accelerated and profitable growth," said Dr. Kelly. "During the year, we recorded two important firsts for Orchid -- a quarterly operating profit and a quarterly positive operating cash flow. While we did incur higher than expected Sarbanes Oxley compliance and audit costs particularly in the fourth quarter which negatively impacted our operating results for the full year, we are pleased with both our quarterly and full year results for 2004 as they clearly reflect our progress in increasing revenues and controlling expenses in our operations."
Dr. Kelly continued, "Our outlook for 2005 reflects our intensified efforts to capture additional market share and enter into new and profitable growth areas, and to leverage our highly scalable operational infrastructure. In addition, our efforts to recruit a chief financial officer are well underway and we look forward to reporting our progress on that appointment soon."
2004 Company Highlights Business Operations
-- Orchid continued to increase its forensics business in the U.S. in
both casework and CODIS testing areas. Orchid was awarded an
exclusive $2.7 million three-year contract by the Los Angeles Police
Department to conduct forensic DNA analysis for new cases as well as
testing for backlogged cases. Also, Orchid was awarded an exclusive,
multi-million dollar one-year contract to test more than 100,000
felons for the State of Illinois for inclusion in the national CODIS
database. The contract is the largest state CODIS contract to date
and was awarded following a competitive bid process.
-- Orchid continued to increase its U.K. forensics DNA testing market
share with the addition of an exclusive three-year multi-million
dollar contract to provide services to Thames Valley Police, one of
the U.K.'s largest police forces and its largest non-metropolitan
police force. The contract was awarded through Orchid's strategic
partner Forensic Alliance.
-- Orchid helped the innovative New York City Police Department (NYPD)
Biotracks pilot program identify its first burglary suspect by
matching DNA from crime scene evidence to DNA databases of convicted
criminals. Orchid proposed this new application of DNA forensic
analysis in the U.S. based on its successful experience supporting a
similar program in the U.K.
-- Orchid entered into new private human identification and family
relationship testing segments. In addition to new agreements to
provide DNA testing for immigration and adoption applications, Orchid
launched its IDSecure service designed to ensure that workers on high
risk assignments can be accurately identified in the event of an
emergency or accident. Orchid has already partnered with a number of
undisclosed firms to provide its IDSecure service.
-- The U.K. government renewed Orchid's scrapie genotyping contract for
an additional two years, and the company expects to continue to be a
major service provider to the U.K. government as part of its National
Scrapie Plan. In 2004, Orchid passed the one million mark in the
number of sheep analyzed for its customers since 2001. In a separate
announcement today, Orchid launched a new scrapie susceptibility kit
designed for customers with lower-throughput testing requirements who
want to benefit from Orchid's highly accurate and robust proprietary
genotyping assay when conducting sheep genotyping in their own
laboratories.
-- Orchid continued to enter into new agriculture markets. Orchid was
selected by Maple Leaf Foods to be the exclusive provider of high
throughput DNA testing for a large-scale Canadian pork traceability
program that represents the first commercial application of DNA
technology for pork traceability. During the year, Orchid
successfully developed the assay technology and completed high
throughput genotyping services for the pilot phase of the program. Financial
-- In the first quarter of 2004, Orchid embarked on a capital
restructuring effort which included a reverse stock split of 1-for-5,
the conversion of all of its outstanding Series A convertible
preferred stock, and a common stock private equity financing that
raised gross proceeds of $30.3 million. Management
-- Orchid strengthened its Board of Directors with the director
appointments of Mr. James Beery and Mr. Gordon Wasserman. Mr. Beery
has more than 30 years experience as a lawyer in international
business and corporate transactions and is currently Senior Of Counsel
to the law firm Covington & Burling. Mr. Wasserman is an
internationally known expert in criminal justice science and
technology and is currently chief executive officer of the consulting
firm The Gordon Wasserman Group, LLC.
-- Orchid fortified its management team with the appointments of Nicholas
Conti, Ph.D., to the newly created position of vice president of
corporate development and Warren T. Meltzer, Esq., to the newly
created position of vice president of legal affairs and general
counsel. Dr. Conti most recently served as vice president, research
and development and business operations of a new unit at Becton
Dickinson & Company. Mr. Meltzer brings to Orchid nearly 20 years of
legal experience, including almost a decade at publicly-traded
companies. Financial Outlook
Orchid provided the following financial guidance:
-- Orchid expects top-line revenues of between $75 million and $78
million for the full year of 2005, which represents an increase of 20
to 24 percent over 2004.
-- Orchid expects an average gross margin of approximately 46 percent for
the full year of 2005.
-- Orchid expects slightly higher total general and administrative, sales
and marketing and research and development expenses for the full year
of 2005 primarily due to an increase in sales and marketing
expenditures.
-- Orchid expects to achieve positive operating income for the full year
of 2005.
-- Orchid expects capital expenditures of between $3.5 million and $4.5
million for the full year of 2005. Conference Call Information
A conference call with Orchid management will be held on Thursday, March 10, 2005 at 10:00 am ET. To listen to the conference call, please dial 1-719-457-2659 and ask for the Orchid Conference Call. To listen to the live or archived webcast via the Internet, please visit the Investors section of Orchid's web site, http://www.orchid.com. The webcast will be archived for 90 days.
About Orchid BioSciences
Orchid BioSciences is a leading provider of identity genetics services for the forensic and paternity DNA testing markets and for public health and animal DNA testing for food safety. Orchid's strong market positions in these segments leverage the Company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark and GeneScreen brands that have been associated with exceptional quality, reliability, innovation and customer service for nearly two decades. More information on Orchid can be found at http://www.orchid.com .
All statements in this press release that are not historical are forward-looking statements within the meaning of Private Securities Litigation Reform Act of 1995, including statements regarding Orchid's expectation that the President's DNA Initiative will be a catalyst for broad-based DNA testing in the U.S. criminal justice system in the future and that this represents a substantial market opportunity for laboratories like Orchid; Orchid's expectation that it expects to continue to be a major service provider to the U.K. government as part of its National Scrapie Plan; Orchid's expectation of achieving top-line revenues of between $75 million and $78 million for the full year of 2005; Orchid's expectation of achieving average gross margin of approximately 46 percent for the full year of 2005; Orchid's expectation of achieving slightly higher total general and administrative, sales and marketing and research and development expenses for the full year of 2005; Orchid's expectation of achieving positive operating income for the full year of 2005; and Orchid's expectation of having capital expenditures of between $3.5 million and $4.5 million for the full year of 2005. Such statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of Orchid products and services, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, patent protection, litigation and Orchid's ability to obtain additional financing. These risks and other additional factors affecting Orchid's business are discussed under the headings "Risks Related to Our Business," "Risks Related to the Biotechnology Industry" and "Risks Associated with Our Common Stock" in Orchid's Annual Report on Form 10-K for the year ended December 31, 2003, as filed with the Securities and Exchange Commission, and in other filings made by Orchid with the Securities and Exchange Commission from time to time. Orchid expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Orchid's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based, except as may be required by law.
Orchid BioSciences, Inc.
and Subsidiaries
Condensed Consolidated Statements of Operations
Three and Twelve months ended December 31, 2004 and December 31, 2003
(In thousands, except per share data)
(unaudited) Three months ended Twelve months ended
Dec 31, Dec 31,
2004 2003 2004 2003
Revenues:
Service revenues $16,489 $12,599 $60,970 $49,140
Other revenues 1,138 1,093 1,529 1,487
Total revenues 17,627 13,692 62,499 50,627
Operating expenses:
Cost of service revenues 9,148 7,651 34,963 29,014
Research and development 335 209 1,632 3,215
Marketing and sales 1,662 1,395 7,041 6,087
General and administrative 5,100 5,447 22,360 23,495
Impairment 393 - 393 837
Restructuring - 231 1,130 76
Amortization of intangible assets 433 447 1,785 1,807
Total operating expenses 17,071 15,380 69,304 64,531
Operating income (loss) 556 (1,688) (6,805) (13,904)
Total other income
(expense), net (168) (228) (103) 1,218
Income (loss) from
continuing operations
before income taxes 388 (1,916) (6,908) (12,686)
Income tax benefit (expense) 457 (36) (1,121) (1,645)
Income (loss) from
continuing operations 845 (1,952) (8,029) (14,331)
Discontinued operations:
Loss from operations of a business
held for sale (177) (4,027) (783) (9,237)
Net income (loss) 668 (5,979) (8,812) (23,568)
Dividends to Series A Preferred
Shareholders - (94) (14) (534)
Accretion of Series A Preferred Stock
discount - (1,217) (1,129) (2,645)
Beneficial conversion feature of
redeemable preferred stock - - - (744)
Net income (loss) allocable
to common stockholders $668 $(7,290) $(9,955) $(27,491)
Basic and diluted income (loss) from
continuing operations
per share allocable to common
stockholders $0.04 $(0.21) $(0.42) $(1.42)
Basic and diluted loss from
discontinued operations
per share $(0.01) $(0.26) $(0.04) $(0.72)
Basic and diluted net income (loss)
per share allocable to
common stockholders $0.03 $(0.46) $(0.46) $(2.14) Shares used in per share data
computations:
Basic 23,038 15,724 21,828 12,831
Diluted 23,657 15,724 21,828 12,831 Orchid BioSciences, Inc.
and Subsidiaries
Condensed Consolidated Balance Sheets
December 31, 2004 and December 31, 2003
(In thousands)
(unaudited) December 31, December 31,
Assets: 2004 2003
Current Assets
Cash and cash equivalents $24,487 $9,938
Short-term Investments 5,999 -
Restricted cash 251 953
Accounts receivable, net 14,099 9,976
Inventory 1,358 1,172
Prepaid and other current assets 1,296 2,583
Assets of a business component
held for sale - 4,595 Total current assets 47,490 29,217 Fixed assets, net 9,977 11,071 Other assets
Goodwill, net 2,789 2,686
Intangible assets, net 13,285 14,942
Restricted cash 1,736 1,113
Other assets 114 400 Total other assets 17,924 19,141 Total assets $75,391 $59,429 Liabilities and Stockholders' Equity: Accounts payable $2,603 $4,768
Accrued expenses 8,273 7,520
Income Taxes Payable 1,982 2,451
Current portion of long-term debt 371 1,889
Deferred revenue 983 1,812
Liabilities of a business component
held for sale - 3,156
Total current liabilities 14,212 21,596 Long Term Liabilities
Long term debt - 415
Long term portion of
restructuring 1,029 782
Other liabilities 1,900 1,592
Total long term liabilities 2,929 2,789 Redeemable Convertible Preferred
Stock (a) - 3,897 Total stockholders' equity 58,250 31,147 Total Liabilities and Stockholders'
Equity $75,391 $59,429
(a) All oustanding shares have been converted into common stock subsequent to December 31, 2003.
--------------------------------------------------------------------------------
Source: Orchid BioSciences
+++++++++++++++++++++++++++++++++++++
This same DICUT QUILLIAM?
++++++++++++++++
ForRelease.com
the archive
Find more about:
AnythingGeorgiaJAVA Group, Inc.
OLDER NEWER
JAVA Announces Profitable Sale of Parkaire Skating Rink Lease in Marietta, GA
MARIETTA, Ga., Feb. 26 /PRNewswire/ -- JAVA Group, Inc. (Pink Sheets: JVGI), a Marietta, Georgia health and entertainment provider, announces today that it has sold its recently acquired Parkaire Skating Rink of Marietta, GA.
The Company further added that an approximate profit of $40,000.00US was made on the sale of this lease to an undisclosed buyer.
Pierre Quilliam, Chief financial officer of JAVA Group, Inc., stated, "this sale offered an immediate turn-key revenue generation for the Company. We will continue to look for profitable acquisitions, and/or the profitable sale of assets in selected fields of operations in the ensuing months ahead."
The Company further reiterates it will continue to seek and evaluate all potential profitable acquisitions and/or sales of assets similar to the Parkaire Skating Rink which fits JAVA's business plan, improves its financial health and its desire to increase shareholder equity.
For Further information about this release and the business at JAVA Group, Inc., contact: Pierre Quilliam, 770-795-9955, fax: 770-795-9222.
About JAVA Group, Inc.
Founded in 1989, JAVA Group, Inc., provides health and entertainment to the public and private sectors.
Except for the historical information contained herein, this press release contains forward-looking statements within meaning of Section 21E of the Securities and Exchange Act of 1934, as amended that involve a number of risks and uncertainties. Forward-looking statements may be identified by reference and future periods by use of forward-looking terminology such as "expect," "anticipate," "could," "would," "will," and "may" and other words of similar nature. There are certain important factors and risks that could cause results to differ materially from those anticipated by the statements herein. Such factors and risks include successful completion of aforementioned acquisitions and ongoing developments of the core business model, the business conditions and growth in related areas of health and entertainment sectors and in the economy in general. Competitive factors include rapid pace of competitive venues and the Company's ability to gain market acceptances. Neither JAVA Group, Inc. nor its subsidiaries undertake any obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: Pierre Quilliam of JAVA Group, Inc., +1-770-795-9955,
fax: +1-770-795-9222
Copyright 2004 PRNewswire
Issued: 02/26/2004 04:56 PM GMT
+++++++++++++++++++++
Java Group?????
Not as slow as:
++++++++++++
Oddly Enough - Reuters
Heaven Can Wait, Court Tells Dying Man
Oddly Enough - Reuters
ROME (Reuters) - A man given six months to live by his doctors has been told by an Italian court to come back in 14 months to hear the outcome of his demand for insurance damages.
Carmelo Cisabella, 39, has an inoperable spine disease and is anxious to pick up some $596,300 in already-agreed damages from his insurers to help ease his final months of life, Il Messaggero newspaper reported Tuesday.
In a bid to speed up the process, Cisabella turned to the Sicilian courts to put pressure on the slow-moving insurers, but was told to return next year to hear their decision.
In his frustration, he chained himself to the gates of the law courts to bring attention to his plight.
Il Messaggero said Cisabella's woes dated back more than a decade when he was left paralyzed by a motorcycle accident. Confined to a wheelchair, he subsequently developed a lethal infection of the spine.
The insurance claim dates back to the road crash.
Italian justice is notoriously slow and it takes on average 3,041 days to obtain a definitive sentence in a civil case.
+++++++++++++++++++++++++++
Everything seems very very slow these days!
Stakddek
I think:
That if the police take your DNA as part of an identification sweep, and it is used for just that limited purpose, I could care less. Unless I'm Guilty!
If the police use that sample of your DNA and do additional medical testing to see if your genes sequence for a possible condition that might require specialized medical attention, or alert you or me to a possible bad drug interraction potential, well I'd be kind of happy to give them a sample any time they asked. (I might even go try to find them so I could "volunteer"!)
If the samples got sent on to my insurance company and were used as the basis for them to raise my health insurance rates, well I'd be kinda' ticked off. But if my dna was used by my insurance company to make sure the medications I was being prescribed were both safe and cost effective, well I wouldn't complain about that. Now how could I trust my insurance company with doing the right thing and not the bad thing with that DNA info??
I guess the only way would be if the testing was performed by a reputable source that would only release the information that was appropriate for a given party. Of course this would require a tremendous database of info, and much of it would have to be segregated to prevent the right info from being routed to the wrong entity.
Probably have to be one very complex computer system with multiple safeguards. (I mean after you run a dna check on all available sources for comparison, do you try to hack into the medical database or CODIS to determine your paternity?)
Someone out there is probably already using the standard geaneology resources to see if madame "x" would make a good spouse. A repository with the depth and breadth that DNAP will require will be a target for both paid and casual hackers. Of course this opens up the possibility of perhaps a best "scientific" guess as to who would be the best choice for producing a future olympic hero etc. Most of us would be happy with just knowing that we would be or not be blessed with 5 fingers and five toes on each appendage so we would either agree to adopt or look for a less risky partner.
Now this isn't out there yet, (in giga-sized use) but we are aware that some "genetic arrangements" have occurred among sperm or egg donors. We are also aware that some diseases are more prevalent within limited genetic pools, and many who have had family members touched by these "genetic conditions" are quite willing to seek counseling and "any" reasonable method to prevent an additional victim of the genetic fault.
(Some people for reasons of religion etc. do not feel this is the way to go, but a lot of folks are aware of genetics now and are willing at least to consider it in family planning.)
Yes friends, male pattern baldness is a curse .... well nevermind...
stakddek
Who are Biofrontera Investors???
++++++++++++++ From Biofrontera Website +++++++++++++++
shareholders
DNAPrint genomics Inc.
Heidelberg Innovation
3i Group Investments LP, London
LeVenture Kapitalbeteiligungsgesellschaft mbH & Co. KG, Leverkusen
TechnoMedia Kapitalbeteiligungsgesellschaft Köln mbH, Köln
Prof. Dr. Riesner
TRE Holding AG, Zürich
tbg Technologie-Beteiligungs-Gesellschaft mbH der Deutschen Ausgleichsbank, Bonn
PRICAP Venture Partners AG, Hamburg
Richard Gabriel
Monica Tamborini
Founder
Employees
++++++++++++++++++++
Perhaps this is listed by percentage of ownership????? They don't say, so I can't.
Stakddek